{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:04:11Z","timestamp":1790283851149,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T00:00:00Z","timestamp":1463961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T00:00:00Z","timestamp":1463961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32HL7101-39"],"award-info":[{"award-number":["T32HL7101-39"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL095987"],"award-info":[{"award-number":["HL095987"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s11897-016-0289-5","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T09:04:22Z","timestamp":1464080662000},"page":"119-131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling"],"prefix":"10.1007","volume":"13","author":[{"given":"Wynn G.","family":"Hunter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob P.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Robert W.","family":"McGarrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svati H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,23]]},"reference":[{"key":"289_CR1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/494416a","volume":"28","author":"M Baker","year":"2013","unstructured":"Baker M. Big biology: the \u2019omes puzzle. Nature. 2013;28:416\u20139.","journal-title":"Nature"},{"issue":"1","key":"289_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nm.2280","volume":"17","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Dai Y, Wen J, et al. Detrimental effects of adenosine signaling in sickle cell disease. Nat Med. 2011;17(1):79\u201386. doi:\n                      10.1038\/nm.2280\n                      \n                    .","journal-title":"Nat Med"},{"issue":"4","key":"289_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard CB, An J, Bain JR, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9(4):311\u201326. doi:\n                      10.1016\/j.cmet.2009.02.002\n                      \n                    .","journal-title":"Cell Metab"},{"issue":"4 Pt 2","key":"289_CR4","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/pr.2013.1","volume":"73","author":"S Moco","year":"2013","unstructured":"Moco S, Collino S, Rezzi S, Martin F-PJ. Metabolomics perspectives in pediatric research. Pediatr Res. 2013;73(4 Pt 2):570\u20136. doi:\n                      10.1038\/pr.2013.1\n                      \n                    .","journal-title":"Pediatr Res"},{"issue":"2","key":"289_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/CIRCGENETICS.109.852814","volume":"3","author":"SH Shah","year":"2010","unstructured":"Shah SH, Bain JR, Muehlbauer MJ, et al. Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Circ Cardiovasc Genet. 2010;3(2):207\u201314. doi:\n                      10.1161\/CIRCGENETICS.109.852814\n                      \n                    .","journal-title":"Circ Cardiovasc Genet"},{"issue":"5","key":"289_CR6","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ahj.2012.02.005","volume":"163","author":"SH Shah","year":"2012","unstructured":"Shah SH, Sun J-L, Stevens RD, et al. Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease. Am Heart J. 2012;163(5):844\u2013850.e1. doi:\n                      10.1016\/j.ahj.2012.02.005\n                      \n                    .","journal-title":"Am Heart J"},{"issue":"1","key":"289_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2013.10.036","volume":"232","author":"S Bhattacharya","year":"2014","unstructured":"Bhattacharya S, Granger CB, Craig D, et al. Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization. Atherosclerosis. 2014;232(1):191\u20136. doi:\n                      10.1016\/j.atherosclerosis.2013.10.036\n                      \n                    .","journal-title":"Atherosclerosis"},{"issue":"1","key":"289_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1373\/clinchem.2011.169573","volume":"58","author":"EP Rhee","year":"2012","unstructured":"Rhee EP, Gerszten RE. Metabolomics and cardiovascular biomarker discovery. Clin Chem. 2012;58(1):139\u201347. doi:\n                      10.1373\/clinchem.2011.169573\n                      \n                    .","journal-title":"Clin Chem"},{"issue":"15","key":"289_CR9","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.jacc.2015.02.018","volume":"65","author":"M-L Cheng","year":"2015","unstructured":"Cheng M-L, Wang C-H, Shiao M-S, et al. Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics. J Am Coll Cardiol. 2015;65(15):1509\u201320. doi:\n                      10.1016\/j.jacc.2015.02.018\n                      \n                    . One of the largest and most rigorous analyses of metabolomic profiles in heart failure to date.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"289_CR10","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/nmeth.3584","volume":"12","author":"H Link","year":"2015","unstructured":"Link H, Fuhrer T, Gerosa L, Zamboni N, Sauer U. Real-time metabolome profiling of the metabolic switch between starvation and growth. Nat Methods. 2015;12(11):1091\u20137. doi:\n                      10.1038\/nmeth.3584\n                      \n                    .","journal-title":"Nat Methods"},{"key":"289_CR11","doi-asserted-by":"publisher","unstructured":"Kraus WE, Muoio DM, Stevens R, et al. Metabolomic Quantitative Trait Loci (mQTL) mapping implicates the ubiquitin proteasome system in cardiovascular disease pathogenesis. Lusis AJ, ed. PLoS Genet. 2015;11(11):e1005553. doi:\n                      10.1371\/journal.pgen.1005553\n                      \n                    .","DOI":"10.1371\/journal.pgen.1005553"},{"issue":"2","key":"289_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1161\/CIRCGENETICS.114.000223","volume":"8","author":"SH Shah","year":"2015","unstructured":"Shah SH, Newgard CB. Integrated metabolomics and genomics: systems approaches to biomarkers and mechanisms of cardiovascular disease. Circ Cardiovasc Genet. 2015;8(2):410\u20139. doi:\n                      10.1161\/CIRCGENETICS.114.000223\n                      \n                    .","journal-title":"Circ Cardiovasc Genet"},{"issue":"11","key":"289_CR13","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1056\/NEJMra063052","volume":"356","author":"S Neubauer","year":"2007","unstructured":"Neubauer S. The failing heart\u2014an engine out of fuel. N Engl J Med. 2007;356(11):1140\u201351. doi:\n                      10.1056\/NEJMra063052\n                      \n                    .","journal-title":"N Engl J Med"},{"issue":"13","key":"289_CR14","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jacc.2014.04.083","volume":"64","author":"W Doehner","year":"2014","unstructured":"Doehner W, Frenneaux M, Anker SD. Metabolic impairment in heart failure. J Am Coll Cardiol. 2014;64(13):1388\u2013400. doi:\n                      10.1016\/j.jacc.2014.04.083\n                      \n                    . One of the most comprehensive and nuanced reviews of metabolic impairments in heart failure to date.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"289_CR15","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.7326\/0003-4819-12-8-1233","volume":"12","author":"G Herrmann","year":"1939","unstructured":"Herrmann G, Decherd GM. The chemical nature of heart failure. Ann Intern Med. 1939;12(8):1233. doi:\n                      10.7326\/0003-4819-12-8-1233\n                      \n                    .","journal-title":"Ann Intern Med"},{"issue":"6","key":"289_CR16","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1161\/CIRCULATIONAHA.114.014420","volume":"131","author":"DW Kitzman","year":"2015","unstructured":"Kitzman DW, Upadhya B, Vasu S. What the dead can teach the living: systemic nature of heart failure with preserved ejection fraction. Circulation. 2015;131(6):522\u20134. doi:\n                      10.1161\/CIRCULATIONAHA.114.014420\n                      \n                    .","journal-title":"Circulation"},{"issue":"1","key":"289_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1161\/CIRCRESAHA.115.302922","volume":"115","author":"K Sharma","year":"2014","unstructured":"Sharma K, Kass DA. Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. Circ Res. 2014;115(1):79\u201396. doi:\n                      10.1161\/CIRCRESAHA.115.302922\n                      \n                    .","journal-title":"Circ Res"},{"issue":"4","key":"289_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tsch\u00f6pe C. A novel paradigm for heart failure with preserved ejection fraction. J Am Coll Cardiol. 2013;62(4):263\u201371. doi:\n                      10.1016\/j.jacc.2013.02.092\n                      \n                    .","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"289_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/eurjhf\/hfr173","volume":"14","author":"H Ardehali","year":"2012","unstructured":"Ardehali H, Sabbah HN, Burke MA, et al. Targeting myocardial substrate metabolism in heart failure: potential for new therapies. Eur J Heart Fail. 2012;14(2):120\u20139. doi:\n                      10.1093\/eurjhf\/hfr173\n                      \n                    . Thorough, sophisticated review of metabolic derangements in heart failure, with emphasis on myocardial energetics.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"289_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11897-015-0257-5","volume":"12","author":"B Upadhya","year":"2015","unstructured":"Upadhya B, Haykowsky MJ, Eggebeen J, Kitzman DW. Sarcopenic obesity and the pathogenesis of exercise intolerance in heart failure with preserved ejection fraction. Curr Heart Fail Rep. 2015;12(3):205\u201314. doi:\n                      10.1007\/s11897-015-0257-5\n                      \n                    .","journal-title":"Curr Heart Fail Rep"},{"issue":"1","key":"289_CR21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1096\/fj.14-255901","volume":"29","author":"C Aguer","year":"2015","unstructured":"Aguer C, McCoin CS, Knotts TA, et al. Acylcarnitines: potential implications for skeletal muscle insulin resistance. FASEB J. 2015;29(1):336\u201345. doi:\n                      10.1096\/fj.14-255901\n                      \n                    .","journal-title":"FASEB J"},{"issue":"3","key":"289_CR22","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","volume":"85","author":"WC Stanley","year":"2005","unstructured":"Stanley WC. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85(3):1093\u2013129. doi:\n                      10.1152\/physrev.00006.2004\n                      \n                    .","journal-title":"Physiol Rev"},{"issue":"1","key":"289_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1152\/physrev.00015.2009","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk GD, Ussher JR, Folmes CDL, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010;90(1):207\u201358. doi:\n                      10.1152\/physrev.00015.2009\n                      \n                    .","journal-title":"Physiol Rev"},{"issue":"4","key":"289_CR24","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/CIRCRESAHA.114.301863","volume":"114","author":"AN Carley","year":"2014","unstructured":"Carley AN, Taegtmeyer H, Lewandowski ED. Matrix revisited: mechanisms linking energy substrate metabolism to the function of the heart. Circ Res. 2014;114(4):717\u201329. doi:\n                      10.1161\/CIRCRESAHA.114.301863\n                      \n                    .","journal-title":"Circ Res"},{"issue":"9","key":"289_CR25","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jacc.2008.08.081","volume":"53","author":"MA AlZadjali","year":"2009","unstructured":"AlZadjali MA, Godfrey V, Khan F, et al. Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure. J Am Coll Cardiol. 2009;53(9):747\u201353. doi:\n                      10.1016\/j.jacc.2008.08.081\n                      \n                    .","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"289_CR26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0735-1097(97)00185-X","volume":"30","author":"JW Swan","year":"1997","unstructured":"Swan JW, Anker SD, Walton C, et al. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol. 1997;30(2):527\u201332. doi:\n                      10.1016\/S0735-1097(97)00185-X\n                      \n                    .","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"289_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/ehf2.12035","volume":"2","author":"W Doehner","year":"2015","unstructured":"Doehner W, Turhan G, Leyva F, et al. Skeletal muscle weakness is related to insulin resistance in patients with chronic heart failure. ESC Heart Failure. 2015;2(2):85\u20139. doi:\n                      10.1002\/ehf2.12035\n                      \n                    .","journal-title":"ESC Heart Failure"},{"key":"289_CR28","doi-asserted-by":"publisher","unstructured":"Paolillo S, Rengo G, Pellegrino T, et al. Insulin resistance is associated with impaired cardiac sympathetic innervation in patients with heart failure. Eur Heart J - Cardiovasc Imaging. 2015;(2015):611\u2013661. doi:\n                      10.1093\/ehjci\/jev061\n                      \n                    .","DOI":"10.1093\/ehjci\/jev061"},{"issue":"6","key":"289_CR29","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jacc.2005.02.093","volume":"46","author":"W Doehner","year":"2005","unstructured":"Doehner W, Rauchhaus M, Ponikowski P, et al. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol. 2005;46(6):1019\u201326. doi:\n                      10.1016\/j.jacc.2005.02.093\n                      \n                    .","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"289_CR30","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/ejhf.337","volume":"17","author":"SJ Greene","year":"2015","unstructured":"Greene SJ, Fonarow GC. Insulin resistance in heart failure: widening the divide between reduced and preserved ejection fraction? Eur J Heart Fail. 2015;17(10):991\u20133. doi:\n                      10.1002\/ejhf.337\n                      \n                    .","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"289_CR31","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cmet.2012.01.024","volume":"15","author":"CB Newgard","year":"2012","unstructured":"Newgard CB. Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab. 2012;15(5):606\u201314. doi:\n                      10.1016\/j.cmet.2012.01.024\n                      \n                    .","journal-title":"Cell Metab"},{"issue":"9","key":"289_CR32","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.2337\/dc08-2075","volume":"32","author":"KM Huffman","year":"2009","unstructured":"Huffman KM, Shah SH, Stevens RD, et al. Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care. 2009;32(9):1678\u201383. doi:\n                      10.2337\/dc08-2075\n                      \n                    .","journal-title":"Diabetes Care"},{"issue":"4","key":"289_CR33","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00125-009-1637-8","volume":"53","author":"ES Tai","year":"2010","unstructured":"Tai ES, Tan MLS, Stevens RD, et al. Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia. 2010;53(4):757\u201367. doi:\n                      10.1007\/s00125-009-1637-8\n                      \n                    .","journal-title":"Diabetologia"},{"issue":"4","key":"289_CR34","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/j.ijcard.2013.08.042","volume":"168","author":"L Tenori","year":"2013","unstructured":"Tenori L, Hu X, Pantaleo P, et al. Metabolomic fingerprint of heart failure in humans: a nuclear magnetic resonance spectroscopy analysis. Int J Cardiol. 2013;168(4):e113\u20135. doi:\n                      10.1016\/j.ijcard.2013.08.042\n                      \n                    .","journal-title":"Int J Cardiol"},{"issue":"11","key":"289_CR35","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1039\/c3mb70227h","volume":"9","author":"J Wang","year":"2013","unstructured":"Wang J, Li Z, Chen J, et al. Metabolomic identification of diagnostic plasma biomarkers in humans with chronic heart failure. Mol BioSyst. 2013;9(11):2618\u201326. doi:\n                      10.1039\/c3mb70227h\n                      \n                    .","journal-title":"Mol BioSyst"},{"issue":"4","key":"289_CR36","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/aje\/kwt004","volume":"178","author":"Y Zheng","year":"2013","unstructured":"Zheng Y, Yu B, Alexander D, et al. Associations between metabolomic compounds and incident heart failure among African Americans: the ARIC study. Am J Epidemiol. 2013;178(4):534\u201342. doi:\n                      10.1093\/aje\/kwt004\n                      \n                    . To our knowledge, this is the largest association study of metabolite profiles with incident heart failure to date.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"289_CR37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1365-2362.2010.02441.x","volume":"41","author":"D Alexander","year":"2010","unstructured":"Alexander D, Lombardi R, Rodriguez G, Mitchell MM, Marian AJ. Metabolomic distinction and insights into the pathogenesis of human primary dilated cardiomyopathy. Eur J Clin Invest. 2010;41(5):527\u201338. doi:\n                      10.1111\/j.1365-2362.2010.02441.x\n                      \n                    . One of the largest and most rigorous assessments of metabolomic profiles in patients with nonischemic cardiomyopathy.","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"289_CR38","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s11306-007-0063-5","volume":"3","author":"WB Dunn","year":"2007","unstructured":"Dunn WB, Broadhurst DI, Deepak SM, et al. Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate. Metabolomics. 2007;3(4):413\u201326. doi:\n                      10.1007\/s11306-007-0063-5\n                      \n                    .","journal-title":"Metabolomics"},{"issue":"4","key":"289_CR39","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.clinbiochem.2010.11.010","volume":"44","author":"S-M Kang","year":"2011","unstructured":"Kang S-M, Park J-C, Shin M-J, et al. 1H nuclear magnetic resonance based metabolic urinary profiling of patients with ischemic heart failure. Clin Biochem. 2011;44(4):293\u20139. doi:\n                      10.1016\/j.clinbiochem.2010.11.010\n                      \n                    . Successfully discriminated patients with heart failure and reduced ejection fraction from healthy controls using metabolomic profiling of urine samples, instead of plasma.","journal-title":"Clin Biochem"},{"issue":"5","key":"289_CR40","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/152165400410182","volume":"49","author":"MCMW Gray","year":"2000","unstructured":"Gray MCMW. Pseudouridine in RNA: what, where, how, and why. IUBMB Life. 2000;49(5):341\u201351. doi:\n                      10.1080\/152165400410182\n                      \n                    .","journal-title":"IUBMB Life"},{"issue":"5","key":"289_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124844","volume":"10","author":"BN Zordoky","year":"2015","unstructured":"Zordoky BN, Sung MM, Ezekowitz J, et al. Metabolomic fingerprint of heart failure with preserved ejection fraction. PLoS ONE. 2015;10(5), e0124844. doi:\n                      10.1371\/journal.pone.0124844\n                      \n                    . To our knowledge, this is the first and only metabolomic analysis that compares plasma metabolite profiles of patients with heart failure and preserved ejection to those of patients with heart failure and reduced ejection fraction.","journal-title":"PLoS ONE"},{"issue":"1","key":"289_CR42","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12967-015-0661-3","volume":"13","author":"M Deidda","year":"2015","unstructured":"Deidda M, Piras C, Dessalvi CC, et al. Metabolomic approach to profile functional and metabolic changes in heart failure. J Transl Med. 2015;13(1):297. doi:\n                      10.1186\/s12967-015-0661-3\n                      \n                    .","journal-title":"J Transl Med"},{"issue":"4","key":"289_CR43","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3109\/1354750X.2013.781222","volume":"18","author":"H Luan","year":"2013","unstructured":"Luan H, Chen X, Zhong S, et al. Serum metabolomics reveals lipid metabolism variation between coronary artery disease and congestive heart failure: a pilot study. Biomarkers. 2013;18(4):314\u201321. doi:\n                      10.3109\/1354750X.2013.781222\n                      \n                    .","journal-title":"Biomarkers"},{"issue":"13","key":"289_CR44","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.jacc.2012.12.033","volume":"61","author":"MA Samara","year":"2013","unstructured":"Samara MA, Tang WHW, Cikach Jr F, et al. Single exhaled breath metabolomic analysis identifies unique breathprint in patients with acute decompensated heart failure. J Am Coll Cardiol. 2013;61(13):1463\u20134. doi:\n                      10.1016\/j.jacc.2012.12.033\n                      \n                    .","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"289_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060737","volume":"8","author":"F Desmoulin","year":"2013","unstructured":"Desmoulin F, Galinier M, Trouillet C, et al. Metabonomics analysis of plasma reveals the lactate to cholesterol ratio as an independent prognostic factor of short-term mortality in acute heart failure. PLoS ONE. 2013;8(4), e60737. doi:\n                      10.1371\/journal.pone.0060737\n                      \n                    .","journal-title":"PLoS ONE"},{"issue":"2","key":"289_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088102","volume":"9","author":"Z Du","year":"2014","unstructured":"Du Z, Shen A, Huang Y, et al. 1H-NMR-based metabolic analysis of human serum reveals novel markers of myocardial energy expenditure in heart failure patients. PLoS ONE. 2014;9(2), e88102. doi:\n                      10.1371\/journal.pone.0088102\n                      \n                    .","journal-title":"PLoS ONE"},{"issue":"2","key":"289_CR47","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/0891988709358592","volume":"23","author":"DC Steffens","year":"2010","unstructured":"Steffens DC, Jiang W, Krishnan KRR, et al. Metabolomic differences in heart failure patients with and without major depression. J Geriatr Psychiatry Neurol. 2010;23(2):138\u201346. doi:\n                      10.1177\/0891988709358592\n                      \n                    .","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"13","key":"289_CR48","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1161\/CIRCULATIONAHA.108.816116","volume":"119","author":"AT Turer","year":"2009","unstructured":"Turer AT, Stevens RD, Bain JR, et al. Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia\/reperfusion. Circulation. 2009;119(13):1736\u201346. doi:\n                      10.1161\/CIRCULATIONAHA.108.816116\n                      \n                    .","journal-title":"Circulation"},{"issue":"5","key":"289_CR49","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1161\/01.CIR.85.5.1751","volume":"85","author":"H Drexler","year":"1992","unstructured":"Drexler H, Riede U, Munzel T, Konig H, Funke E, Just H. Alterations of skeletal muscle in chronic heart failure. Circulation. 1992;85(5):1751\u20139. doi:\n                      10.1161\/01.CIR.85.5.1751\n                      \n                    .","journal-title":"Circulation"},{"issue":"11","key":"289_CR50","doi-asserted-by":"publisher","first-page":"E990","DOI":"10.1152\/ajpendo.00602.2014","volume":"308","author":"CS McCoin","year":"2015","unstructured":"McCoin CS, Knotts TA, Ono-Moore KD, Oort PJ, Adams SH. Long-chain acylcarnitines activate cell stress and myokine release in C2C12 myotubes: calcium-dependent and -independent effects. Am J Physiol Endocrinol Metab. 2015;308(11):E990\u20131000. doi:\n                      10.1152\/ajpendo.00602.2014\n                      \n                    .","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"12","key":"289_CR51","doi-asserted-by":"publisher","first-page":"E1378","DOI":"10.1152\/ajpendo.00656.2013","volume":"306","author":"JM Rutkowsky","year":"2014","unstructured":"Rutkowsky JM, Knotts TA, Ono-Moore KD, et al. Acylcarnitines activate proinflammatory signaling pathways. Am J Physiol Endocrinol Metab. 2014;306(12):E1378\u201387. doi:\n                      10.1152\/ajpendo.00656.2013\n                      \n                    .","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"9","key":"289_CR52","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.060368","volume":"126","author":"SH Shah","year":"2012","unstructured":"Shah SH, Kraus WE, Newgard CB. Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. Circulation. 2012;126(9):1110\u201320. doi:\n                      10.1161\/CIRCULATIONAHA.111.060368\n                      \n                    .","journal-title":"Circulation"},{"issue":"4","key":"289_CR53","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s11306-011-0345-9","volume":"8","author":"DK Thompson","year":"2011","unstructured":"Thompson DK, Sloane R, Bain JR, et al. Daily variation of serum acylcarnitines and amino acids. Metabolomics. 2011;8(4):556\u201365. doi:\n                      10.1007\/s11306-011-0345-9\n                      \n                    .","journal-title":"Metabolomics"},{"key":"289_CR54","doi-asserted-by":"publisher","unstructured":"Shah SJ, Katz DH, Selvaraj S, et al. Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation. 2014:CIRCULATIONAHA.114.010637. doi:\n                      10.1161\/CIRCULATIONAHA.114.010637\n                      \n                    .","DOI":"10.1161\/CIRCULATIONAHA.114.010637"},{"issue":"17","key":"289_CR55","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.jacc.2014.07.979","volume":"64","author":"T Ahmad","year":"2014","unstructured":"Ahmad T, Pencina MJ, Schulte PJ, et al. Clinical implications of chronic heart failure phenotypes defined by cluster analysis. J Am Coll Cardiol. 2014;64(17):1765\u201374. doi:\n                      10.1016\/j.jacc.2014.07.979\n                      \n                    .","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"289_CR56","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/j.jacc.2015.03.043","volume":"65","author":"JP Kelly","year":"2015","unstructured":"Kelly JP, Mentz RJ, Mebazaa A, et al. Patient selection in heart failure with preserved ejection fraction clinical trials. J Am Coll Cardiol. 2015;65(16):1668\u201382. doi:\n                      10.1016\/j.jacc.2015.03.043\n                      \n                    .","journal-title":"J Am Coll Cardiol"},{"issue":"5 Pt 1","key":"289_CR57","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S0002-8703(97)80007-5","volume":"134","author":"RM Bersin","year":"1997","unstructured":"Bersin RM, Stacpoole PW. Dichloroacetate as metabolic therapy for myocardial ischemia and failure. Am Heart J. 1997;134(5 Pt 1):841\u201355.","journal-title":"Am Heart J"},{"issue":"3","key":"289_CR58","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jchf.2014.09.009","volume":"3","author":"RM Beadle","year":"2015","unstructured":"Beadle RM, Williams LK, Kuehl M, et al. Improvement in cardiac energetics by perhexiline in heart failure due to dilated cardiomyopathy. J Am Coll Cardiol HF. 2015;3(3):202\u201311. doi:\n                      10.1016\/j.jchf.2014.09.009\n                      \n                    .","journal-title":"J Am Coll Cardiol HF"},{"issue":"16","key":"289_CR59","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1161\/CIRCULATIONAHA.109.934059","volume":"122","author":"K Abozguia","year":"2010","unstructured":"Abozguia K, Elliott P, McKenna W, et al. Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy. Circulation. 2010;122(16):1562\u20139. doi:\n                      10.1161\/CIRCULATIONAHA.109.934059\n                      \n                    .","journal-title":"Circulation"},{"issue":"1","key":"289_CR60","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000375288","volume":"131","author":"S Grajek","year":"2015","unstructured":"Grajek S, Michalak M. The effect of trimetazidine added to pharmacological treatment on all-cause mortality in patients with systolic heart failure. Cardiology. 2015;131(1):22\u20139. doi:\n                      10.1159\/000375288\n                      \n                    .","journal-title":"Cardiology"},{"issue":"5","key":"289_CR61","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jacc.2006.03.060","volume":"48","author":"G Fragasso","year":"2006","unstructured":"Fragasso G, Palloshi A, Puccetti P, et al. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure. J Am Coll Cardiol. 2006;48(5):992\u20138. doi:\n                      10.1016\/j.jacc.2006.03.060\n                      \n                    .","journal-title":"J Am Coll Cardiol"},{"key":"289_CR62","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/msb.2009.11","volume":"5","author":"SH Shah","year":"2009","unstructured":"Shah SH, Hauser ER, Bain JR, et al. High heritability of metabolomic profiles in families burdened with premature cardiovascular disease. Mol Syst Biol. 2009;5:258. doi:\n                      10.1038\/msb.2009.11\n                      \n                    .","journal-title":"Mol Syst Biol"},{"issue":"4","key":"289_CR63","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm.2307","volume":"17","author":"TJ Wang","year":"2011","unstructured":"Wang TJ, Larson MG, Vasan RS, et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17(4):448\u201353. doi:\n                      10.1038\/nm.2307\n                      \n                    .","journal-title":"Nat Med"},{"issue":"10","key":"289_CR64","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1172\/JCI35111","volume":"118","author":"GD Lewis","year":"2008","unstructured":"Lewis GD, Wei R, Liu E, et al. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest. 2008;118(10):3503\u201312. doi:\n                      10.1172\/JCI35111\n                      \n                    .","journal-title":"J Clin Invest"}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-016-0289-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11897-016-0289-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-016-0289-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-016-0289-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T17:45:02Z","timestamp":1589737502000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11897-016-0289-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,23]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["289"],"URL":"https:\/\/doi.org\/10.1007\/s11897-016-0289-5","relation":{},"ISSN":["1546-9530","1546-9549"],"issn-type":[{"value":"1546-9530","type":"print"},{"value":"1546-9549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,23]]},"assertion":[{"value":"23 May 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Wynn G. Hunter, Jacob P. Kelly, William E. Kraus, Robert W. McGarrah, and Svati H. Shah declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}